RESTEM Launches NK Cell Therapy Program with Publication of Results from Clinical Study of NK Cell Therapy Targeting Senescence and Age-Associated Disorders
Corona, CA (PRWEB) November 21, 2022 -- • Proof-of-Concept Study Demonstrates Effective Senescent Cell Elimination• Transitioning Program to Expanded Human